These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 8051975)

  • 41. [Second-line treatment of metastatic non-small cell lung carcinoma: What are the options today? What are the perspectives for tomorrow?].
    Greillier L; Barlesi F
    Rev Mal Respir; 2012 Jan; 29(1):4-6. PubMed ID: 22240212
    [No Abstract]   [Full Text] [Related]  

  • 42. [Chemotherapy of bronchial carcinoma].
    Drings P
    Prax Klin Pneumol; 1988 Jun; 42 Suppl 1():340-3. PubMed ID: 2459687
    [No Abstract]   [Full Text] [Related]  

  • 43. [Chemotherapy in the treatment of advanced metastatic non-small cell carcinoma of the lung].
    Cortesi E; Nelli F
    Suppl Tumori; 2004; 3(2):S52-5. PubMed ID: 15067969
    [No Abstract]   [Full Text] [Related]  

  • 44. [Local and systemic therapy of non-small cell lung carcinoma (NSCLC)].
    Gatzemeier U; Griesinger F; Huber RM; Thomas M
    Onkologie; 2010; 33 Suppl 5():1. PubMed ID: 20523100
    [No Abstract]   [Full Text] [Related]  

  • 45. Adjuvant chemotherapy in new stage II pN0 non-small cell lung cancer: a new issue for a case-by-case decision making process.
    De Pas T; de Braud F; Veronesi G
    J Thorac Oncol; 2010 May; 5(5):754. PubMed ID: 20421773
    [No Abstract]   [Full Text] [Related]  

  • 46. Lung cancer.
    Giaccone G; Smit E
    Cancer Chemother Biol Response Modif; 2003; 21():445-83. PubMed ID: 15338759
    [No Abstract]   [Full Text] [Related]  

  • 47. [Genomic approaches to tailored therapy in non-small cell lung cancer].
    Song Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 Dec; 31(12):889-90. PubMed ID: 19134403
    [No Abstract]   [Full Text] [Related]  

  • 48. Is the use of chemotherapy justified in non-small-cell lung cancer?
    Kelly P; Clancy L
    Drugs Aging; 1994 Jan; 4(1):1-8. PubMed ID: 8130379
    [No Abstract]   [Full Text] [Related]  

  • 49. Induction therapy for stage III lung cancer.
    Johnston MR
    Lung Cancer; 2003 Dec; 42 Suppl 2():S53-7. PubMed ID: 14644537
    [No Abstract]   [Full Text] [Related]  

  • 50. Non-small cell lung cancer: second-line and beyond.
    Stahel RA
    Ann Oncol; 2006 Sep; 17 Suppl 10():x97-100. PubMed ID: 17018760
    [No Abstract]   [Full Text] [Related]  

  • 51. Cytotoxic chemotherapy in advanced non-small cell lung cancer.
    Scagliotti GV; Novello S; Selvaggi G
    Monaldi Arch Chest Dis; 2005 Dec; 63(4):181-3. PubMed ID: 16454216
    [No Abstract]   [Full Text] [Related]  

  • 52. Outcomes of palliative chemotherapy in stage IV non-small cell lung cancer. Have we found what we are looking for?
    Tassinari D; Papi M; Fochessati F; Poggi B; Fantini M; Tamburini E; Ravaioli A
    Lung Cancer; 2004 Mar; 43(3):373-4. PubMed ID: 15165101
    [No Abstract]   [Full Text] [Related]  

  • 53. PACIFIC: An Ocean of Hope in Patients With Stage III Unresectable Non-Small Cell Lung Cancer.
    Uprety D; Marinier DE
    J Natl Compr Canc Netw; 2018 May; 16(5):458-460. PubMed ID: 29752318
    [No Abstract]   [Full Text] [Related]  

  • 54. Targeted adjuvant therapy in non-small cell lung cancer: trick or treat?
    Hendriks LEL; van Meerbeeck J; Cadranel J
    Eur Respir J; 2021 Oct; 58(4):. PubMed ID: 34711606
    [No Abstract]   [Full Text] [Related]  

  • 55. A lung cancer responding to hormonal therapy.
    Collins IM; Nicholson SA; O'Byrne KJ
    J Thorac Oncol; 2010 May; 5(5):749-50. PubMed ID: 20421769
    [No Abstract]   [Full Text] [Related]  

  • 56. Non small cell lung cancer patients with ECOG PS2: unsolved questions and lessons from clinical trials.
    Gebbia V; Galetta D; De Marinis F
    Ann Oncol; 2005 May; 16 Suppl 4():iv123-131. PubMed ID: 15923412
    [No Abstract]   [Full Text] [Related]  

  • 57. Cetuximab and non-small-cell lung cancer: end of the story?
    Rossi A
    Lancet Oncol; 2013 Dec; 14(13):1251-3. PubMed ID: 24231626
    [No Abstract]   [Full Text] [Related]  

  • 58. Surgical approaches in special situations.
    Goldberg M
    Curr Probl Cancer; 1996; 20(3):179-96. PubMed ID: 8866209
    [No Abstract]   [Full Text] [Related]  

  • 59. Chemotherapy for non-small-cell lung carcinoma, a look at the past decade.
    Monnerat C; Le Chevalier T
    Ann Oncol; 2000 Jul; 11(7):773-6. PubMed ID: 10997802
    [No Abstract]   [Full Text] [Related]  

  • 60. Histological transformation from non-small cell to small cell lung carcinoma.
    Haruta Inoue Y; Kataoka Y; Nikaido J; Nakajima N
    BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27543609
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.